Literature DB >> 1093758

Return of elevated blood pressure after withdrawal of antihypertensive drugs.

.   

Abstract

The rate at which arterial pressure rises after discontinuing active treatment was investigated in a group of 86 hypertensive patients who received treatment with hydrochlorothiazide, reserpine and hydralazine for two years or longer and whose diastolic pressures averaged below 96 mm Hg for the last year of treatment. Sixty patients were assigned double-blind to placebos and 26 were continued on active drugs. Forty-two of the placebo group of patients were removed over an 18 month follow-up because of return of elevated blood pressures, 39 being removed in the first six months. Six patients in the placebo group and none in the treated group were removed because of morbid events. Nine or 15% of the placebo patients remained normotensive. The rate of rise in arterial pressure in the placebo group appeared to be related directly to the height of the pressure prior to initiation of active treatment and inversely to the age of the patients. Serum uric acid fell significantly while serum potassium rose significantly after active treatment was discontinued. The glucose tolerance test changed slightly in a direction toward normal while serum creatinine showed no significant change.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1093758     DOI: 10.1161/01.cir.51.6.1107

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

Review 1.  Prehypertension: a possible target for antihypertensive medication.

Authors:  S D Nesbitt; S Julius
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

Review 2.  Risks versus benefits of withdrawing antihypertensive therapy.

Authors:  H P Schobel; R E Schmieder; F H Messerli
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

3.  A practical approach to hypertension.

Authors:  A Dodek; G Wilkins
Journal:  Can Fam Physician       Date:  1976-12       Impact factor: 3.275

Review 4.  When is discontinuation of antihypertensive therapy indicated?

Authors:  R E Schmieder; J K Rockstroh
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

Review 5.  Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction.

Authors:  D J van Kraaij; R W Jansen; F W Gribnau; W H Hoefnagels
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

6.  A controlled study of the antihypertensive effect of carteolol, a new beta-adrenergic receptor blocking drug, in combination with hydrochlorothiazide and amiloride.

Authors:  A Tarkiainen; K Saraste; T Seppälä; A Gordin; J Auvinen
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

7.  An incremental model to isolate specific effects of behavioral treatments in essential hypertension.

Authors:  M Goebel; G W Viol; C Orebaugh
Journal:  Biofeedback Self Regul       Date:  1993-12

8.  Prescription of hypotensives in general practice: a study of 4 Norwegian counties in October 1975.

Authors:  I Baksaas; P Fugelli; I K Halvorsen; P K Lunde; K Naess
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

Review 9.  Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertension.

Authors:  G H Gibbons; V J Dzau
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

10.  The likelihood of remaining normotensive following antihypertensive drug withdrawal.

Authors:  A Mitchell; R B Haynes; C A Adsett; A Bellissimo; N Wilczynski
Journal:  J Gen Intern Med       Date:  1989 May-Jun       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.